Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

Similar articles for PubMed (Select 23402420)

1.

Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study.

Hall RG 2nd, Hazlewood KA, Brouse SD, Giuliano CA, Haase KK, Frei CR, Forcade NA, Bell T, Bedimo RJ, Alvarez CA.

BMC Pharmacol Toxicol. 2013 Feb 13;14:12. doi: 10.1186/2050-6511-14-12.

2.

Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study.

Hall RG 2nd, Giuliano CA, Haase KK, Hazlewood KA, Frei CR, Forcade NA, Brouse SD, Bell T, Bedimo RJ, Alvarez CA.

BMC Infect Dis. 2012 Apr 27;12:104. doi: 10.1186/1471-2334-12-104.

3.

Empiric weight-based vancomycin in intensive care unit patients with methicillin-resistant Staphylococcus aureus bacteremia.

Alvarez CA, Giuliano CA, Haase KK, Thompson KA, Frei CR, Forcade NA, Brouse SD, Mortensen EM, Bell T, Bedimo RJ, Toups NM, Hall RG 2nd.

Am J Med Sci. 2014 Nov;348(5):371-6. doi: 10.1097/MAJ.0000000000000262.

PMID:
24762747
4.

Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections.

Hermsen ED, Hanson M, Sankaranarayanan J, Stoner JA, Florescu MC, Rupp ME.

Expert Opin Drug Saf. 2010 Jan;9(1):9-14. doi: 10.1517/14740330903413514.

PMID:
20021290
5.

Impact of empiric weight-based vancomycin dosing on nephrotoxicity and mortality in geriatric patients with methicillin-resistant Staphylococcus aureus bacteraemia.

Hall RG 2nd, Blaszczyk AT, Thompson KA, Brouse SD, Giuliano CA, Frei CR, Forcade NA, Mortensen EM, Bell T, Bedimo RJ, Alvarez CA.

J Clin Pharm Ther. 2014 Dec;39(6):653-7. doi: 10.1111/jcpt.12203. Epub 2014 Sep 8.

PMID:
25200273
6.

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.

Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JC, Thom KA, Cosgrove SE, Sakoulas G, Perencevich EN.

BMC Infect Dis. 2011 Oct 19;11:279. doi: 10.1186/1471-2334-11-279.

7.

Nephrotoxicity of vancomycin in patients with methicillin-resistant Staphylococcus aureus bacteraemia.

Shen WC, Chiang YC, Chen HY, Chen TH, Yu FL, Tang CH, Sue YM.

Nephrology (Carlton). 2011 Nov;16(8):697-703. doi: 10.1111/j.1440-1797.2011.01488.x.

PMID:
21707841
9.

Comparative epidemiology of bacteremia due to methicillin-resistant Staphylococcus aureus between older and younger adults: a propensity score analysis.

Kullar R, Rybak MJ, Kaye KS.

Infect Control Hosp Epidemiol. 2013 Apr;34(4):400-6. doi: 10.1086/669868. Epub 2013 Feb 15.

PMID:
23466914
10.

Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort.

Kullar R, Davis SL, Taylor TN, Kaye KS, Rybak MJ.

Pharmacotherapy. 2012 Mar;32(3):195-201. doi: 10.1002/j.1875-9114.2011.01017.x. Erratum in: Pharmacotherapy. 2012 Sep;32(9):869.

PMID:
22392452
11.

Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?

Hazlewood KA, Brouse SD, Pitcher WD, Hall RG.

Am J Med. 2010 Feb;123(2):182.e1-7. doi: 10.1016/j.amjmed.2009.05.031. Review.

12.

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.

Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A.

Arch Intern Med. 2006 Oct 23;166(19):2138-44.

PMID:
17060545
13.

Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial.

Bosso JA, Nappi J, Rudisill C, Wellein M, Bookstaver PB, Swindler J, Mauldin PD.

Antimicrob Agents Chemother. 2011 Dec;55(12):5475-9. doi: 10.1128/AAC.00168-11. Epub 2011 Sep 26.

15.

Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.

Murray KP, Zhao JJ, Davis SL, Kullar R, Kaye KS, Lephart P, Rybak MJ.

Clin Infect Dis. 2013 Jun;56(11):1562-9. doi: 10.1093/cid/cit112. Epub 2013 Feb 28.

16.
17.

Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy.

Joo J, Yamaki J, Lou M, Hshieh S, Chu T, Shriner KA, Wong-Beringer A.

Clin Ther. 2013 Jul;35(7):995-1004. doi: 10.1016/j.clinthera.2013.05.018. Epub 2013 Jul 2.

PMID:
23829982
18.

Lack of vancomycin-associated nephrotoxicity in newborn infants: a case-control study.

Bhatt-Mehta V, Schumacher RE, Faix RG, Leady M, Brenner T.

Pediatrics. 1999 Apr;103(4):e48.

PMID:
10103340
19.
20.

The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia.

Honda H, Doern CD, Michael-Dunne W Jr, Warren DK.

BMC Infect Dis. 2011 Dec 5;11:335. doi: 10.1186/1471-2334-11-335.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk